Methylphenidate Beneficial in ADHD After 2 or More Years

Methylphenidate was effective in the long-term treatment of attention-deficit/hyperactivity disorder (ADHD), according to study data published in the American Journal of Psychiatry…These data also support existing recommendations that patients receive periodic assessment to determine if there is a continued need for methylphenidate treatment.

Read More

How Anxiety Changes ADHD Symptoms With Age

Having ADHD + anxiety can complicate diagnosis and treatment. Symptoms of the two conditions can reinforce each other, contradict each other, or have nothing to do with each other depending on context. But psychology researchers are gradually making progress in understanding how ADHD and anxiety disorders fit together.

Read More

Teen Drivers with ADHD More Likely to Crash

According to a new study, teen drivers suffering from attention-deficit hyperactivity disorder (ADHD) are more likely to engage in risky driving behaviors, particularly after receiving their driver’s license for the first time. Researchers conducted a longitudinal study comprised of 14,936 teen drivers who received their license between January 2004 and December 2014. These drivers were…

Read More

Guanfacine vs. Adderall: What is the difference?

In the case of Adderall, it is a stimulant. Conversely, guanfacine is a nonstimulant. In this respect, they are taken in different ways and may have different side effects. The best option for each person depends on their specific symptoms, needs, and personal preferences. People usually use guanfacine only if stimulant medications are not appropriate.

Read More

Is YouTube a Reliable Source for Information About ADHD?

In the case of ADHD, this give-and-take is even trickier because people are using online content to inform their understanding of a mental health condition. For that reason, a group of researchers decided to watch the most viewed YouTube videos about ADHD and assess how accurate the information those videos provided was.

Read More

Telepsychiatry helping teens with mental health disorders

The Harris Health System’s pediatric telepsychiatry program began late last year. Right now, the program sees about 20 patients a week. At least 1 in 5 young people have a diagnosable mental health disorder that is impairing their lives. Now there’s a new affordable program to help them and their families: telemedicine for pediatric patients.

Read More

Adhansia XR Soon to Be Available for ADHD

Adhansia XR (methylphenidate HCl extended-release capsules) is expected to be available by the end of July 2019 for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years of age and older, according to Adlon Therapeutics.

Read More